What's new

Human medicines European public assessment report (EPAR): Tresiba, insulin degludec, Date of authorisation: 20/01/2013, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Tresiba, insulin degludec, Date of authorisation: 20/01/2013, Revision: 19, Status: Authorised

Jun 27, 2025 - 15:10
 0
Human medicines European public assessment report (EPAR): Tresiba, insulin degludec, Date of authorisation: 20/01/2013, Revision: 19, Status: Authorised
Human medicines European public assessment report (EPAR): Tresiba, insulin degludec, Date of authorisation: 20/01/2013, Revision: 19, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Da...

Next Article

Human medicines European public assessment report (EPAR): Saxenda, liraglutide, ...

Related Posts

Human medicines European public assessment report (EPAR): Sugammadex Piramal, sugammadex, Date of authorisation: 23/06/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 12, 2025  0

Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0

EMEA-002746-PIP01-20-M03

EMEA-002746-PIP01-20-M03

Jun 6, 2025  0